BPG is committed to discovery and dissemination of knowledge
JOURNAL HOME
Number of total visits
4423987
Number of visits today
908
Number of downloads
4060642
MEMBERSHIP
BPG JOURNALS
Cited by in F6Publishing
For: Oo WM, Hunter DJ. Repurposed and investigational disease-modifying drugs in osteoarthritis (DMOADs). Therapeutic Advances in Musculoskeletal 2022;14:1759720X2210902. [DOI: 10.1177/1759720x221090297] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Staebler S, Lichtblau A, Gurbiel S, Schubert T, Riechers A, Rottensteiner-Brandl U, Bosserhoff A. MIA/CD-RAP Regulates MMP13 and Is a Potential New Disease-Modifying Target for Osteoarthritis Therapy. Cells 2023;12. [PMID: 36672165 DOI: 10.3390/cells12020229] [Reference Citation Analysis]
2 Tenti S, Bruyère O, Cheleschi S, Reginster JY, Veronese N, Fioravanti A. An update on the use of conventional and biological disease-modifying anti-rheumatic drugs in hand osteoarthritis. Ther Adv Musculoskelet Dis 2023;15:1759720X231158618. [PMID: 36937821 DOI: 10.1177/1759720X231158618] [Reference Citation Analysis]
3 Schäfer N, Grässel S. Targeted therapy for osteoarthritis: progress and pitfalls. Nat Med 2022;28:2473-5. [PMID: 36456832 DOI: 10.1038/s41591-022-02057-x] [Reference Citation Analysis]
4 García-Couce J, Schomann T, Chung CK, Que I, Jorquera-Cordero C, Fuentes G, Almirall A, Chan A, Cruz LJ. Thermosensitive Injectable Hydrogels for Intra-Articular Delivery of Etanercept for the Treatment of Osteoarthritis. Gels 2022;8:488. [PMID: 36005089 DOI: 10.3390/gels8080488] [Reference Citation Analysis]
5 Oo WM, Mobasheri A, Hunter DJ. A narrative review of anti-obesity medications for obese patients with osteoarthritis. Expert Opin Pharmacother 2022. [PMID: 35855642 DOI: 10.1080/14656566.2022.2104636] [Reference Citation Analysis]
Write to the Help Desk
© 2004-2023 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

California Corporate Number: 3537345